all report title image
  • Published On : Dec 2023
  • Code : CMI6336
  • Pages : 150
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image

Sildenafil which is commonly known as the "little blue pill," is a widely used drug primarily used to treat erectile dysfunction (ED). It belongs to the class of medications called phosphodiesterase type 5 (PDE5) inhibitors and is marketed under the brand name Viagra. Sildenafil works by relaxing the smooth muscles of the blood vessels in the penis, thereby allowing for increased blood flow and ultimately facilitating an erection.

Since its introduction in the late 1990s, sildenafil has revolutionized the field of ED treatment, providing relief to millions of men worldwide. It has become the go-to medication for individuals experiencing difficulties in achieving and maintaining an erection, thereby offering an effective solution that has transformed the lives of many.

Market Dynamics:

The sildenafil drug market is expected to witness significant growth in the forecast period. The key drivers for this growth include the increasing prevalence of erectile dysfunction worldwide, the growing aging population, and the rising awareness regarding sexual health.

However, the market has also challenges. The significant restraint is the presence of counterfeit sildenafil products in the market, which can pose serious health risks to consumers. Regulatory bodies and pharmaceutical companies are making efforts to crack down on counterfeit drugs.

Despite these challenges, the sildenafil market presents several opportunities. The development of innovative dosage forms, such as orally disintegrating tablets and chewable tablets, offers convenience and ease of administration for patients. The emergence of generic versions of sildenafil is expected to drive the market growth by making the drug more affordable and accessible.

Key Features of the Study:

  • This report provides an in-depth analysis of the sildenafil drug market, including market size (in US$ Bn) and compound annual growth rate (CAGR %) for the forecast period of 2023-2030, with 2022 as the base year
  • The study explores potential revenue opportunities across different market segments and presents attractive investment propositions for this market
  • It offers key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • The report profiles key players in the global sildenafil drug market, highlighting their company background, product portfolio, key accomplishments, financial performance, and strategies
  • The study includes key companies such as Pfizer, Teva Pharmaceuticals, Aurobindo Pharma, Alembic Pharmaceuticals, Torrent Pharmaceuticals, Lupin, Dr Reddy’s Laboratories, Zydus Cadila, Amneal Pharmaceuticals, Hetero, Apotex, Mylan, Ajanta Pharma, Sun Pharmaceutical, Cipla, Novartis, Eli Lily, Sanofi, Bayer, and GlaxoSmithKline.
  • The insights provided by this report would enable marketers and management authorities to make informed decisions regarding product launches, upgrades, market expansion, and marketing tactics
  • Various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts, would benefit from the findings of this report
  • Stakeholders can leverage the strategy matrices used in analyzing the sildenafil drug market to facilitate decision-making processes

Detailed Segmentation:

  • Sildenafil Drug Market, By Drug Type
    • Branded Drugs
    • Generic Drugs
    • Over The Counter Drugs
  • Sildenafil Drug Market, By Indication
    • Erectile Dysfunction
    • Pulmonary Arterial Hypertension
    • Benign Prostatic Hyperplasia
    • Others (Premature Ejaculation, Altitude Sickness)
  • Sildenafil Drug Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Others (Clinics, Mail Order Pharmacies)
  • Sildenafil Drug Market, By Dosage Form
    • Tablets
    • Oral Jellies
    • Injections
    • Others (Suspensions, Capsules)
  • Sildenafil Drug Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in Sildenafil Drug Market:
    • Pfizer
    • Teva Pharmaceuticals
    • Aurobindo Pharma
    • Alembic Pharmaceuticals
    • Torrent Pharmaceuticals
    • Lupin
    • Reddy’s Laboratories
    • Zydus Cadila
    • Amneal Pharmaceuticals
    • Hetero
    • Apotex
    • Mylan
    • Ajanta Pharma
    • Sun Pharmaceutical
    • Cipla
    • Novartis
    • Eli Lily
    • Sanofi
    • Bayer
    • GlaxoSmithKline

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Indication
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Dosage Form
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
        • Increasing prevalence of erectile dysfunction
      • Restraints
        • Adverse effects and safety concerns
      • Opportunities
        • Development of novel drug delivery system
    • Key Highlights
    • Regulatory Scenario
    • Recent Trends
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Mergers, Acquisitions, ad Collaborations
  4. Sildenafil Drug Market – Impact of Coronavirus (COVID-19) Pandemic
    • COVID-19 Epidemiology
    • Supply Side and Demand Side Analysis
    • Economic Impact
  5. Sildenafil Drug Market, By Drug Type, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 – 2030
      • Segment Trends
    • Branded Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    •  Generic Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Over The Counter Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  6. Sildenafil Drug Market, By Indication, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 – 2030
      • Segment Trends
    • Erectile Dysfunction
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Pulmonary Arterial Hypertension
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Benign Prostatic Hyperplasia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Others (Premature Ejaculation, Altitude Sickness)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  7. Sildenafil Drug Market, By Distribution Channel, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 – 2030
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Others (Clinics, Mail Order Pharmacies)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  8. Sildenafil Drug Market, By Dosage Form, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 – 2030
      • Segment Trends
    • Tablets
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Oral Jellies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Injections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Others (Suspensions, Capsules)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  9. Sildenafil Drug Market, By Region, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, By Region, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, For Region, 2019 –2030
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
        • South Africa
        • Central Africa
        • North Africa
  10. Competitive Landscape
    • Company Profile
      • Pfizer
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Teva Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Aurobindo Pharma
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Alembic Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Torrent Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Lupin
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Reddy’s Laboratories
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Zydus Cadila
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Amneal Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Hetero
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Apotex
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Mylan
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Ajanta Pharma
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Sun Pharmaceutical
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Cipla
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Novartis
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Eli Lily
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Sanofi
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Bayer
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • GlaxoSmithKline
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
    • Analyst Views
  11. Section
    • References
    • Research Methodology
    • About us

*Browse 44 market data tables and 39 figures on “Sildenafil Drug Market” - Global forecast to 2030

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo